RETRACTED ARTICLE: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer
Abstract As a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, Fluvastatin (FLV) is used for reducing low-density lipoprotein (LDL) cholesterol as well as to prevent cardiovascular problems. FLV showed cell line cytotoxicity and antitumor effect. Melittin (MEL) exhibits antineoplastic...
Main Authors: | Mohamed A. Alfaleh, Omar Fahmy, Mohammed W. Al-Rabia, Mohammed A. S. Abourehab, Osama A. A. Ahmed, Usama A. Fahmy, Helal H. Alsulimani, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Bander M. Aldhabi, Awaad S. Alharbi, Nabil A. Alhakamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-24151-3 |
Similar Items
-
Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer
by: Mohamed A. Alfaleh, et al.
Published: (2024-11-01) -
Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer
by: Alfaleh, Mohamed A., et al.
Published: (2022) -
Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
by: Shaimaa M. Badr-Eldin, et al.
Published: (2021-02-01) -
Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells
by: Usama A. Fahmy, et al.
Published: (2022-12-01) -
The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
by: Usama A. Fahmy, et al.
Published: (2020-10-01)